CARA Cara Therapeutic

USD 0.35 0.00 0
Icon

Cara Therapeutic (CARA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.35

0.00 (0.00)%

USD 0.02B

1.09M

USD 3.46(+879.92%)

USD 8.25 (+2238.44%)

Icon

CARA

Cara Therapeutic (USD)
COMMON STOCK | NSD
USD 0.35
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.02B

USD 8.25 (+2238.44%)

USD 0.35

Cara Therapeutic (CARA) Stock Forecast

Show ratings and price targets of :
USD 3.46
(+879.92%)

Based on the Cara Therapeutic stock forecast from 4 analysts, the average analyst target price for Cara Therapeutic is USD 3.46 over the next 12 months. Cara Therapeutic’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Cara Therapeutic is Slightly Bearish, which is based on 3 positive signals and 7 negative signals. At the last closing, Cara Therapeutic’s stock price was USD 0.3528. Cara Therapeutic’s stock price has changed by +23.88% over the past week, +0.80% over the past month and -87.66% over the last year.

No recent analyst target price found for Cara Therapeutic
No recent average analyst rating found for Cara Therapeutic

Company Overview Cara Therapeutic

Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-seve...Read More

400 Atlantic Street, Stamford, CT, United States, 06901

55

December

USD

USA

Adjusted Closing Price for Cara Therapeutic (CARA)

Loading...

Unadjusted Closing Price for Cara Therapeutic (CARA)

Loading...

Share Trading Volume for Cara Therapeutic Shares

Loading...

Compare Performance of Cara Therapeutic Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CARA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Cara Therapeutic (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD127.00B 31.94 20.00

ETFs Containing CARA

Symbol Name CARA's Weight Expense Ratio Price(Change) Market Cap

Frequently Asked Questions About Cara Therapeutic (CARA) Stock

Based on ratings from 4 analysts Cara Therapeutic's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 5 buy, sell and 2 hold ratings.

Unfortunately we do not have enough data on CARA's stock to indicate if its a good dividend stock.

Based on targets from 4 analysts, the average taret price for CARA is USD 3.46 over the next 12 months. The maximum analyst target price is USD 5 while the minimum anlayst target price is USD 1.

CARA stock's Price/Earning ratio is 23.13. Our analysis grades CARA stock's Price / Earning ratio at F. This means that CARA stock's Price/Earning ratio is above 75% of the stocks in the Biotechnology sector in the NSD exchange. Based on this CARA may be a overvalued for its sector.

The last closing price of CARA's stock was USD 0.35.

The most recent market capitalization for CARA is USD 0.02B.

Based on targets from 4 analysts, the average taret price for CARA is projected at USD 3.46 over the next 12 months. This means that CARA's stock price may go up by +879.92% over the next 12 months.

We can't find any ETFs which contains Cara Therapeutic's stock.

As per our most recent records Cara Therapeutic has 55 Employees.

Cara Therapeutic's registered address is 400 Atlantic Street, Stamford, CT, United States, 06901. You can get more information about it from Cara Therapeutic's website at https://www.caratherapeutics.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...